Biostem Tech
Price
Price
Frequently asked questions
What is Biostem Tech's market capitalization?
What is Biostem Tech's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Biostem Tech?
What are the analyst ratings and target price for Biostem Tech's stock?
What is Biostem Tech's revenue over the trailing twelve months?
What is the EBITDA for Biostem Tech?
What is the 5-year beta of Biostem Tech's stock?
How many employees does Biostem Tech have, and what sector and industry does it belong to?
What is the free float of Biostem Tech's shares?
Financials
Market Cap
$196.65M5Y beta
1.46EPS (TTM)
$0.63Free Float
16.05MP/E ratio (TTM)
19.10Revenue (TTM)
$210.39MEBITDA (TTM)
$20.73MPricing
Analyst Ratings
Information
BioStem Technologies, Inc. is focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts and regenerative therapies. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. Its products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AmnioWrap2. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. AmnioWrap is a placental-based allografts comprised of unseparated amnion and chorion membranes, including the intact intermediate layer.
67
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker